You Searched For "invitae" and got 19 results
Sort By:
2 mins read
Invitae surges after report says Softbank will lead a $1.2 billion investment in the genetic-testing company
Invitae announced it will acquire the genomics company Genosity for $200 million on Monday after la…
Will Daniel
2 mins read
Ark Invest's flagship fund realized $3.5 billion in losses in a year. Here were its 10 biggest losers.
The last few years have been tough on the speculative growth trade that Cathie Wood's Ark funds hav…
Matthew Fox
12 mins read
Robots and AI are being used to help women get pregnant. Is this the future of IVF?
Conceivable Life Sciences is automating IVF labs to make fertility care less arbitrary. Its robotic…
Blake Dodge
2 mins read
Cathie Wood's flagship ARK fund suffers biggest monthly outflow in nearly a year as performance continues to suffer
Ark's flagship fund still has $8 billion in assets under management, a considerable amount despite …
Matthew Fox
2 mins read
Cathie Wood's flagship Ark ETF slides 7% amid interest rate spike as underperformance spills into 2022
The damage in Ark's portfolio is widespread, with only three of its 45 holdings in the green over t…
Matthew Fox
2 mins read
Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years
Behind Tesla, the third largest holding in the ARKK ETF is CRISPR Therapeutics, a gene editing comp…
Matthew Fox
2 mins read
These are the 10 most beaten-down stocks in Ark Invest's flagship fund as momentum fades for innovative tech bets
Investors in Ark Invest's flagship portfolio have seen the ETF fall 24% year to date while the S&P …
Matthew Fox
1 min read
Cathie Wood's Ark Innovation ETF rises 10% as tech heavyweights like Tesla and Zoom rally
Wood's flagship ETF was been buoyed by the rise in Tesla, its biggest holding, which soared as much…
Isabelle Lee
4 mins read
A genetic testing company you've never heard of could become a household name as it takes on 23andMe
Say you received a result that said you were at a high risk of an arrhythmia, or an irregular heart…
Erin Brodwin
2 mins read
Pacific Biosciences spikes 29% after announcing a $900 million investment from SoftBank
Pacific Biosciences is set to receive a $900 million investment from SoftBank's SB NorthStar unit i…
Will Daniel
2 mins read
A genetics testing company wants to change the way patients contribute to research
"It's really never been done before," Bonnie Addario, founder of the Bonnie J. Addario Lung Cancer …
Lydia Ramsey
3 mins read
Beyoncé's father Mathew Knowles opened up about his breast cancer journey one year after sharing his diagnosis
Mathew Knowles wrote an op-ed for USA Today detailing the stigma around the term "breast cancer" fo…
Taylor Ardrey
2 mins read
The 'app store for genetics' just landed another major partner
Now, Invitae, a company that's been in the genetic testing space for the last six years, wants to g…
Lydia Ramsey
7 mins read
The DNA testing industry is stuck in a rut. Here's how 23andMe and Ancestry are plotting their next moves.
By working with health systems to cover the cost of the test, the hope is to broaden the number of …
Lydia Ramsey
3 mins read
A Chicagoland hospital is adding a new test to its annual checkup - and it could be the future of medicine
One study, recently published in the Annals of Internal Medicine, concluded that when primary-care …
Lydia Ramsey
2 mins read
We'll get you caught up on all the news you missed at the year's biggest healthcare investor conference
Thousands of investors, Wall Street analysts, execs, and of course, journalists, converged on San F…
Zachary Tracer
5 mins read
This former Googler says he's so tired of the astronomical housing prices in San Francisco that he bought land in Austin, Texas instead
Another report by the real estate company Compass found just how costly it can be to buy a home in …
Nick Bastone
8 mins read
The genetic testing business is stuck in a slump. We spoke to industry giants Ancestry and 23andMe about how they're preparing for a comeback.
And then there's the issue of what to do once you get health-related results. While there are clear…
Lydia Ramsey
14 mins read
From suicide prevention to genetic testing, there's a widening disconnect between Silicon Valley health-tech and outside experts who see red flags
Take Juul, which is now the top seller of e-cigarettes in the US. When the San Francisco company la…